DCN and cancer: 3.6.3. Novel Putative Ligands and Receptors with Anti-Cancer Potential: SLIT3, CCN3, DCN, DNASE1L3, SULF1, THBS1, PTEN, OAS1, P2RX4, CDHR2, PTPRs, and DAB2IP